New ADHD drug shows promise for kids in Late-Stage trial

NCT ID NCT05286762

Completed Symptom relief Sponsor: Cingulate Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medication called CTx-1301 (dexmethylphenidate) for children and teens aged 6 to 17 with ADHD. The goal was to see if it reduces ADHD symptoms better than a placebo. 103 participants took either the drug or a placebo, and researchers measured changes in ADHD rating scales and overall severity. The trial is now complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHD ADHD - COMBINED TYPE ATTENTION DEFICIT HYPER ACTIVITY ATTENTION DEFICIT HYPERACTIVITY DISORDER ATTENTION DEFICIT HYPERACTIVITY DISORDER COMBINED ATTENTION-DEFICIT HYPERACTIVITY

Contacts and locations

Locations

Access Clinical Trials Inc.

Nashville, Tennessee, 37203, United States
Atlanta Center for Medical Research

Atlanta, Georgia, 30331, United States
BioBehavioral Research of Austin

Austin, Texas, 78759, United States
Center for Psychiatry and Behavioral Medicine. Inc.

Las Vegas, Nevada, 89128, United States
Clinical Neuroscience Solutions, Inc.

Jacksonville, Florida, 32256, United States
Clinical Neuroscience Solutions, Inc.

Orlando, Florida, 32801, United States
Clinical Neuroscience Solutions, Inc.

Memphis, Tennessee, 38119, United States
Clinical Research Partners LLC

Petersburg, Virginia, 23805, United States
Coastal Carolina Research Center

North Charleston, South Carolina, 29405, United States
Coastal Pediatric Associates

Charleston, South Carolina, 29414, United States
Dayton Clinical Research

Dayton, Ohio, 45409, United States
Family Psychiatry of The Woodlands

Woodland, Texas, 77381, United States
FutureSearch Trials

Dallas, Texas, 75231, United States
Gadolin Research

Beaumont, Texas, 77702, United States
Hassman Research Institute

Berlin, New Jersey, 08009, United States
Houston Clinical Trials

Bellaire, Texas, 77401, United States
Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States
Meridien Research

Maitland, Florida, 32751, United States
Neurobehavioral Medicine Group

Bloomfield Hills, Michigan, 48302, United States
Red Oak Psychiatry Associates, PA

Houston, Texas, 77090, United States
SP Research PLLC

Oklahoma City, Oklahoma, 73112, United States
Sisu Bhr, Llc

Springfield, Massachusetts, 01103, United States
St Charles Psychiatric Associates & Midwest Research Group

Saint Charles, Missouri, 63304, United States
Summit Research Network, LLC

Portland, Oregon, 97210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.